SCHEMBL13299532

SCHEMBL13299532

Cc1ccc2c(c1)nc(-c1ccccc1)n2-c1ccccc1C

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NLRP3 Q96P20 1/20 0.57
TSHR P16473 2/20 0.49
ALDH1A1 P00352 6/20 0.44
L3MBTL1 Q9Y468 2/20 0.44
KDM4E B2RXH2 2/20 0.44
SIRT2 Q8IXJ6 1/20 0.44
SIRT1 Q96EB6 1/20 0.44
GAA P10253 1/20 0.42
PKM P14618 1/20 0.42
HTT P42858 1/20 0.42
ESR1 P03372 1/20 0.41
ESR2 Q92731 1/20 0.41
LMNA P02545 1/20 0.41
ACSS2 Q9NR19 1/20 0.41
FGFR1 P11362 1/20 0.40
PDE10A Q9Y233 1/20 0.40
NPC1 O15118 1/20 0.40
POLB P06746 1/20 0.40
HPGD P15428 1/20 0.40
CASP3 P42574 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13299596 0.87 NLRP3 (0.56) NLRP3ALDH1A1L3MBTL1KDM4ESIRT2
SCHEMBL13299530 0.85 NLRP3 (0.57) NLRP3ALDH1A1L3MBTL1KDM4ESIRT2
SCHEMBL13299515 0.84 TSHR (0.68) TSHRALDH1A1L3MBTL1KDM4EGAA
SCHEMBL13299528 0.83 NLRP3 (0.52) NLRP3ALDH1A1L3MBTL1KDM4ESIRT2
SCHEMBL1104831 0.83 NLRP3 (0.61) NLRP3ALDH1A1L3MBTL1KDM4ESIRT2
SCHEMBL13299529 0.82 NLRP3 (0.57) NLRP3ALDH1A1L3MBTL1KDM4ESIRT2
SCHEMBL10979856 0.82 NLRP3 (0.60) NLRP3ALDH1A1L3MBTL1KDM4ESIRT2
SCHEMBL13299531 0.81 NLRP3 (0.56) NLRP3ALDH1A1L3MBTL1KDM4ESIRT2
SCHEMBL13299543 0.80 NLRP3 (0.52) NLRP3ALDH1A1L3MBTL1KDM4ESIRT2
SCHEMBL13299541 0.80 NLRP3 (0.52) NLRP3ALDH1A1L3MBTL1KDM4ESIRT2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8367223-B2 Heteroleptic phosphorescent emitters UNIVERSAL DISPLAY CORPORATION (US) 2013-02-05 US disclosed
US-8367223-B2 Heteroleptic phosphorescent emitters UNIVERSAL DISPLAY CORPORATION (US) 2013-02-05 US disclosed
US-20100141127-A1 PHOSPHORESCENT EMITTERS UNIVERSAL DISPLAY CORPORATION (US) 2010-06-10 US disclosed
US-20100141127-A1 PHOSPHORESCENT EMITTERS UNIVERSAL DISPLAY CORPORATION (US) 2010-06-10 US disclosed
WO-2010056669-A1 PHOSPHORESCENT EMITTERS UNIVERSAL DISPLAY CORPORATION (US) 2010-05-20 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100141127-A1 PHOSPHORESCENT EMITTERS PAICS, TYMP, NUDT1 NLRP3 651/4885TSHR 4117/4885ALDH1A1 695/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.